Idox plc (GB:IDOX) has released an update.
Idox plc has reported a robust first half of 2024, with a notable 21% increase in revenue to £43.1m, driven by the integration of Emapsite and growth in recurring revenues by 29%. Profitability has also seen an uptick with an 8% rise in adjusted EBITDA to £13.1m and a solid increase in statutory profit before tax by 12%. The company underscores a healthy order intake and a strong M&A pipeline, alongside a positive outlook for the remainder of the year with plans to pay a final dividend.
For further insights into GB:IDOX stock, check out TipRanks’ Stock Analysis page.
